Asia Pacific Newborn Screening

1. Coherent Market Insights Asia Pacific Newborn Screening: A Low-Cost Tool for Screening Infants After Birth to Improve Treatment and Follow-Up Asia Pacific newborn screening is used to screen infants soon after birth for conditions that are treatable but not clinically evident in the neonatal period. Infants are vulnerable to a variety diseases such as polio, asthma, encephaliphitis, epilepsy, polio, chronic obstructive pulmonary disease (COPD), respiratory disease, anemia, leukemia, diarrhea, and other rare diseases that results in substantial economic burden. Asia Pacific newborn screening allows these conditions to be detected at birth, allowing the child to potentially lead a normal and healthy life. Newborn screening describes various tests that are performed during first few hours or days of an infant’s life. These tests have the potential to prevent serious health problems and prevent death. Newborn screening is essentially a medical program of intensive screening in newborn babies just before birth for treatable conditions, but not yet medically proven in the newborn age. Asia Pacific newborn screening helps to reduce the incidence of several conditions which may affect newborn development, and even lead to death of the newborn, before the full term of delivery is reached. Screening is often recommended by pediatricians and other health professionals, even though it is not covered by most health insurance policies. However, screening for certain diseases has been deemed necessary by most regions in Asia Pacific. Read More : https://bit.ly/2TE52Iv Coherent Market Insights